- Home
- MTCH vs LNTH Comparison
MTCH vs LNTH Comparison
Compare MTCH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- LNTH
- Stock Information
- Founded
- MTCH 1986
- LNTH 1956
- Country
- MTCH United States
- LNTH United States
- Employees
- MTCH N/A
- LNTH N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MTCH Technology
- LNTH Health Care
- Exchange
- MTCH Nasdaq
- LNTH Nasdaq
- Market Cap
- MTCH 7.2B
- LNTH 7.5B
- IPO Year
- MTCH 2015
- LNTH 2015
- Fundamental
- Price
- MTCH $29.41
- LNTH $78.81
- Analyst Decision
- MTCH Buy
- LNTH Strong Buy
- Analyst Count
- MTCH 19
- LNTH 5
- Target Price
- MTCH $35.89
- LNTH $133.80
- AVG Volume (30 Days)
- MTCH 5.1M
- LNTH 1.3M
- Earning Date
- MTCH 05-08-2025
- LNTH 05-07-2025
- Dividend Yield
- MTCH 1.29%
- LNTH N/A
- EPS Growth
- MTCH N/A
- LNTH N/A
- EPS
- MTCH 2.02
- LNTH 3.53
- Revenue
- MTCH $3,450,904,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- MTCH $1.02
- LNTH $5.81
- Revenue Next Year
- MTCH $5.01
- LNTH $12.26
- P/E Ratio
- MTCH $14.53
- LNTH $22.33
- Revenue Growth
- MTCH 0.40
- LNTH 12.53
- 52 Week Low
- MTCH $26.39
- LNTH $74.34
- 52 Week High
- MTCH $38.84
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- MTCH 49.41
- LNTH 27.83
- Support Level
- MTCH $26.80
- LNTH $78.61
- Resistance Level
- MTCH $30.76
- LNTH $83.60
- Average True Range (ATR)
- MTCH 0.99
- LNTH 3.82
- MACD
- MTCH -0.05
- LNTH -2.99
- Stochastic Oscillator
- MTCH 60.95
- LNTH 5.64
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.